A copper(II) complex of 6-(pyrazin-2-yl)-1,3,5-triazine-2,4-diamine and L-serinate: synthesis, crystal structure, DNA-binding and molecular docking studies
- 14 February 2018
- journal article
- research article
- Published by Springer Nature in Transition Metal Chemistry
- Vol. 43 (3) , 201-209
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Guangdong Province (2015A030313423)
This publication has 33 references indexed in Scilit:
- Recent development of transition metal complexes with in vivo antitumor activityJournal of Inorganic Biochemistry, 2017
- Transition Metal Intercalators as Anticancer Agents—Recent AdvancesInternational Journal of Molecular Sciences, 2016
- Possible DNA‐Interacting Pathways for Metal‐Based Compounds Exemplified with Copper Coordination CompoundsEuropean Journal of Inorganic Chemistry, 2015
- Synthesis, crystal structures, DNA binding and photoluminescence properties of [Cu(pzta)2Cl]Cl⋅H2O for DNA detectionSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2014
- Advances in Copper Complexes as Anticancer AgentsChemical Reviews, 2013
- Surrogates of 2,2′-Bipyridine Designed to Chelate Ag(I) and Create Metallotectons for Engineering Hydrogen-Bonded CrystalsCrystal Growth & Design, 2011
- The status of platinum anticancer drugs in the clinic and in clinical trialsDalton Transactions, 2010
- Unusual DNA binding modes for metal anticancer complexesBiochimie, 2009
- New trends for metal complexes with anticancer activityCurrent Opinion in Chemical Biology, 2008
- Direct Cellular Responses to Platinum-Induced DNA DamageChemical Reviews, 2007